title: Mabthera® (Rituximab) for the Treatment of Severe Granulomatosis With Polyangiitis (Gpa) and Microscopic Polyangiitis (Mpa) - A Cost-Utility Model for the United Kingdom.
authors.affiliation: Roche Products Limited, Welwyn Garden City, UK.
authors.forename: D
authors.initials: D
authors.lastname: Harland
authors.affiliation: Roche Products Limited, Welwyn Garden City, UK.
authors.forename: B
authors.initials: B
authors.lastname: Naisbett-Groet
authors.affiliation: Symmetron Limited, Herts, UK.
authors.forename: S
authors.initials: S
authors.lastname: Chang
authors.affiliation: Symmetron Limited, Elstree, UK.
authors.forename: D K
authors.initials: DK
authors.lastname: Sungher
authors.affiliation: Symmetron Limited, Herts, UK.
authors.forename: L
authors.initials: L
authors.lastname: Sawyer
authors.affiliation: Symmetron Limited, Borehamwood, UK.
authors.forename: A
authors.initials: A
authors.lastname: Diamantopoulos